- €44.25m
- €83.79m
- €93.68m
Brief: Dr Hoenle Q1 Profit Up 246 Pct At 5.2 Million Euros
Brief: Dr Hoenle FY Consolidated Result Up 25.6 % At EUR 10.414 Million
Brief: Dr Hoenle Comments on FY 2016/2017 And 2017/2018 Forecast
Brief: Dr Hoenle 9-month profit up at EUR 5.9 mln
Brief: Dr Hoenle Q1 sales down 2 pct at 22.18 million euros
Brief: Dr Hoenle FY pre-tax earnings down 14.1 pct to EUR 12.1 mln
Brief: Dr Hoenle 9-Month EBIT down 7.5 pct to 8.785 mln euros
Brief: Dr Hoenle lowers outlook for current FY
Brief: Dr Hoenle H1 sales slightly up at 44.81 million euros
Brief: Dr. Hoenle Aktiengesellschaft FY revenue up 3.9 pct at EUR 22.641 mln
Brief: Dr Hoenle FY 2014/2015 revenue up 12.3 pct at EUR 92.2 mln
Brief: Dr Hoenle 9-month net result up 47.8 pct to EUR 6.71 mln
Brief: Dr Hoenle Aktiengesellschaft H1 EBIT up 55.3 pct to EUR 6.01 mln
Brief: Dr Hoenle's Panacol Elosol to establish joint venture with SKC Co. Ltd.
Brief: Dr Hoenle AG says Karl Hönle took over as chairman of controlling body
Brief: Dr Hoenle appointed Karl Hoenle as chairman of supervisory board
Brief: Dr. Hoenle AG Q1 sales revenues up 7.6 pct to 21,790 thousand euros
Brief: Dr Hoenle reports FY revenue up 6.2 pct to 82.1 mln euros
Brief: Dr. Hoenle 9M sales revenue up by 10.6 % to 61.4 million euros